• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We're Reading: ACA Sign-ups Fall Short; Opposition to Block Grants; and Drug Coupons

Article

Enrollment for ACA Coverage Declined for the First Time

Amid Republican talk to repeal and replace the Affordable Care Act, and a temporary halt on ads calling people to sign up, enrollment through HealthCare.gov dipped. According to POLITICO, 9.2 million people signed up for coverage through HealthCare.gov, a decline over the previous open enrollment season. The deadline to sign up had been January 31, and just days before the Trump administration decided to nix the remainder of the ad campaign calling people to sign up. Enrollment numbers for the 11 states and the District of Columbia that use their own exchanges have yet to be counted.

Block Grant Idea Faces Increased Opposition

Meanwhile, President Donald Trump and Republicans in Congress are facing increased opposition to an idea of using block grants to fund Medicaid. Block grants would provide a fixed amount of money to each state, and opponents say it would reduce benefits, according to Forbes. AARP has come out against the proposed strategy, claiming that it would end guaranteed access to care. With opposition mounting, some think Republicans will back off of block grants—which the party has been interested in for 20 years—and instead turn to per capita caps.

California Bill Bans Drug Coupons

A new bill in California would ban coupons from drug makers to help lower the cost of copayments for some drugs. California Healthline reported that the bill would prohibit coupons for drugs that have cheaper, FDA-approved equivalents. According to assembly member Jim Wood, who introduced the bill, drug coupons are driving patients to use higher-priced drugs, which in turn drive up premiums.

Related Videos
Margaret Krackeler, MD
Margaret Krackeler, MD
Margaret Krackeler, MD
A new study finds law enforcement presence in emergency departments may disrupt care. Lead author Prashasti Bhatnagar discusses policy and training solutions.
Jennifer Snow, MPA, NAMI
Jennifer Snow, MPA, NAMI
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Adam Brufsky, MD, PhD, University of Pittsburgh
Dr Steven Manobianco
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.